Chemokines and chemokine receptors in chronic lymphocytic leukemia (CLL): From understanding the basics towards therapeutic targeting

被引:84
作者
Burger, Jan A. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Unit 428, Dept Leukemia, Houston, TX 77230 USA
关键词
CLL; Chemokines; Chemokine receptors; CXCR4; Plerixafor; REGULATORY T-CELLS; MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA; MALIGNANT B-CELLS; ALPHA MIP-1-ALPHA; CLINICAL ACTIVITY; HODGKIN-LYMPHOMA; NURSELIKE CELLS; TYROSINE KINASE; GENE-EXPRESSION; BONE-DISEASE;
D O I
10.1016/j.semcancer.2010.09.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Chemokines and their receptors organize the recruitment and positioning of cells at each stage of the immune response, a system critically dependent upon coordination to get the right cells to the right place at the right time. Chemokine receptors expressed on CLL B cells are thought to function in a similar fashion, regulating the trafficking of the leukemia cells between blood, lymphoid organs, and the bone marrow, and within sub compartments within these tissues, in concert with adhesion molecules and other guidance cues. CLL cells not only respond to chemokines secreted in the microenvironment, the leukemia cells also secrete chemokines in response to external signals, such as B cell receptor engagement. These CLL cell-derived chemokines facilitate interactions between CLL cells, T cells, and other immune cells that shape the CLL microenvironment. CXCR4, the most prominent chemokine receptor in CLL, is now targeted in a first clinical trial, emphasizing that chemokines and their receptors have become a highly dynamic translational research field. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:424 / 430
页数:7
相关论文
共 100 条
[61]  
Loetscher P, 2000, Adv Immunol, V74, P127
[62]   Chemokine receptors that mediate B cell homing to secondary lymphoid tissues are highly expressed in B cell chronic lymphocytic leukemia and non-Hodgkin lymphomas with widespread nodular dissemination [J].
López-Giral, S ;
Quintana, NE ;
Cabrerizo, M ;
Alfonso-Pérez, M ;
Sala-Valdés, M ;
de Soria, VGG ;
Fernández-Rañada, JM ;
Fernández-Ruiz, E ;
Muñoz, C .
JOURNAL OF LEUKOCYTE BIOLOGY, 2004, 76 (02) :462-471
[63]   Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes [J].
Lossos, IS ;
Czerwinski, DK ;
Alizadeh, AA ;
Wechser, MA ;
Tibshirani, R ;
Botstein, D ;
Levy, R .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (18) :1828-1837
[64]   The antileukemia activity of a human anti-CD40 antagonist antibody, HCD122, on human chronic lymphocytic leukemia cells [J].
Luqman, Mohammad ;
Klabunde, Sha ;
Lin, Karen ;
Georgakis, Georgios V. ;
Cherukuri, Anu ;
Holash, Jocelyn ;
Goldbeck, Cheryl ;
Xu, Xiaomei ;
Kadel, Edward E., III ;
Lee, Sang Hoon ;
Aukerman, Sharon Lea ;
Jallal, Bahija ;
Aziz, Natasha ;
Weng, Wen-Kai ;
Wierda, William ;
O'Brien, Susan ;
Younes, Anas .
BLOOD, 2008, 112 (03) :711-720
[65]   BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis [J].
Luther, SA ;
Lopez, T ;
Bai, W ;
Hanahan, D ;
Cyster, JG .
IMMUNITY, 2000, 12 (05) :471-481
[66]   Moving targets: cell migration inhibitors as new anti-inflammatory therapies [J].
Mackay, Charles R. .
NATURE IMMUNOLOGY, 2008, 9 (09) :988-998
[67]   Overexpression of the chemokine receptor CXCR4 in B cell chronic lymphocytic leukemia is associated with increased functional response to stromal cell-derived factor-1 (SDF-1) [J].
Möhle, R ;
Failenschmid, C ;
Bautz, F ;
Kanz, L .
LEUKEMIA, 1999, 13 (12) :1954-1959
[68]   Lymphocyte traffic control by chemokines [J].
Moser, B ;
Loetscher, P .
NATURE IMMUNOLOGY, 2001, 2 (02) :123-128
[69]   Stromal cell contributions to the homeostasis and functionality of the immune system [J].
Mueller, Scott N. ;
Germain, Ronald N. .
NATURE REVIEWS IMMUNOLOGY, 2009, 9 (09) :618-629
[70]   The impact of CCR7 and CXCR5 on lymphoid organ development and systemic immunity [J].
Müller, G ;
Höpken, UE ;
Lipp, M .
IMMUNOLOGICAL REVIEWS, 2003, 195 :117-135